NCT03149991: A trial that was reported late by Massachusetts General Hospital
This trial has reported, although it was 50 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT03149991 |
|---|---|
| Title | A Double-Blind, Placebo-Controlled Study of Brexpiprazole Plus Ketamine in Treatment-Resistant Depression (TRD) |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Sept. 14, 2017 |
| Completion date | March 31, 2019 |
| Required reporting date | March 30, 2020, midnight |
| Actual reporting date | May 20, 2020 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | 50 |